• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Biotech R&D Platform Benchling Closes $100M at $6B Valuation

by Fred Pennic 11/18/2021 Leave a Comment

Benchling Nabs $34.5M to Power Life Sciences R&D Cloud Platform

What You Should Know: Biotech R&D platform Benchling raises $100M at a $6B valuation, co-led by Franklin Templeton and Altimeter Capital to expand product development and global footprint, particularly in EMEA. More than 200,000 scientists at over 600 companies and 7,000 research institutions globally have adopted Benchling's R&D Cloud to make breakthrough discoveries and bring the next generation of medicines, food, and materials to market faster than ever before. The R&D
Read More

77% of Sponsors, CROs Plan to Run Agile Clinical Trials in Next Months

by Jasmine Pennic 11/17/2021 Leave a Comment

77% of Sponsors, CROs Plan to Run Agile Clinical Trials in Next Months

What You Should Know: - Today Science 37 published a new report suggesting a momentous shift in the way that clinical trials are conducted. - For the first time, more research sponsors and CROs are planning to run Agile/Hybrid Clinical Trials than ever before. Findings show that the vast majority or 77% of respondents plan to run an agile clinical trial in the next 12 months, compared to 59% for the previous 12 months. Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37”), a
Read More

Overcoming Key Hurdles in Decentralized Trials with Better Education

by Robert Geckeler, ScienceMedia Product Director 11/17/2021 Leave a Comment

Overcoming Key Hurdles in Decentralized Trials with Better Education

As with countless global industries, clinical trials were forced to move key functions online as COVID-19 swept the world in early 2020. Clinical research operations had to rapidly deploy remote approaches that were previously in the planning or pilot stages. While the uptake was rushed, the results have been largely positive. Decentralized clinical trials, and their near cousins that apply a hybrid approach of in-person and remote visits, are increasingly seen as a viable solution for biopharma
Read More

Decentralized Clinical Research Will Be A Paradigm-Shifting Trend

by Zeenia Framroze, Director of Strategy and Business Operations at Sharecare 11/12/2021 Leave a Comment

The future of clinical research has arrived

The field of clinical research is on the precipice of change, and for good reason. Traditional clinical trials and processes are primarily confined to sterile, isolated clinical settings that are often narrow in scope and provider-centric. Researchers of tomorrow, however, already are identifying accurate and effective new methods to conduct and draw meaning from their work, after concluding that current models for clinical research are not capturing participants’ real-world, lived experiences
Read More

Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment

by Fred Pennic 11/11/2021 Leave a Comment

What You Should Know: - Coming out of stealth, Notable Labs, a pioneer and developer of predictive precision medicines, is acquiring worldwide development and commercial rights to volasertib, a PLK-1 inhibitor in acute myeloid leukemia (AML) from Oncoheroes. - Notable will leverage its high-fidelity Predictive Precision Medicines Platform to identify and select volasertib-responsive patients prior to their treatment and fast-track volasertib’s clinical development
Read More

Biotech Company Nuritas Raises $45M To Scale Its Peptide Discovery Platform

by Jasmine Pennic 11/11/2021 Leave a Comment

Biotech Company Nuritas Raises $45M To Scale Its Peptide Discovery Platform

What You Should Know: - Nuritas, a biotech company that uses proprietary AI to discover plant-based actives (peptides) and make the products we consume healthier and more sustainable raises $45M in Series B funding led by Cleveland Avenue, LLC. The round also included participation from Cultivian Sandbox Ventures, VisVires New Protein, U2’s Bono and The Edge, Salesforce CEO Marc Benioff and Ali Partovi. - Founded in 2014, Nuritas’ computational approach to discovery uses
Read More

3 Barriers to Decentralized Clinical Trials Adoption

by Michael Delisle, VP, Practice Leader for Digital Health at GattiHR 11/09/2021 Leave a Comment

3 Barriers to Decentralized Clinical Trials Adoption

It’s official. Decentralized clinical trials have disrupted the clinical trial process for good. The COVID-19 pandemic elevated many digital innovations, proving that virtually connecting with patients is not only convenient but necessary when it comes to providing equitable access to cutting-edge treatments and clinical research. Historically, traditional clinical trials have always experienced recruitment and retention challenges due to inconveniently located trial sites, lack of awareness
Read More

Decentralized Clinical Trials: Keys to Optimizing Diversity and Inclusion

by Michael Delisle, VP, Practice Leader for Digital Health at GattiHR 11/03/2021 Leave a Comment

Decentralized Clinical Trials: Keys to Optimizing Diversity and Inclusion

The U.S. pharma industry and research intuitions have long struggled with increasing clinical trial diversity in an effective, sustainable, and scalable fashion. Clinical research, in general, acknowledges the universal struggle of recruiting enough participants from various demographic groups. For example, racial and ethnic minorities have been historically underrepresented in clinical trials—a problem that still persists today. According to Deloitte, African Americans comprise 13% of the
Read More

Medable Secures $304M at $2.1B Valuation for Decentralized Clinical Trials Platform

by Fred Pennic 10/26/2021 Leave a Comment

Medable Secures $304M at $2.1B Valuation for Decentralized Clinical Trials Platform

What You Should Know: - Decentralized Clinical Trials (DCT) leader Medable, today announced a $304M Series D funding round today – the company’s largest and fourth funding round in 18 months, bringing total capital raised to $521M – and valuation to $2B+. The funding round was co-led by new investors Blackstone Growth and Tiger Global and existing investor GSR Ventures. The round also includes follow-on investment from existing investors Sapphire
Read More

Cerner Enviza Launches to Accelerate Therapies and Improve Patient Outcomes

by Jasmine Pennic 10/26/2021 Leave a Comment

Cerner Enviza Launches to Accelerate Therapies and Improve Patient Outcomes

What You Should Know: - Today, Cerner announced the launch of Cerner Enviza, a new operating unit that offers solutions to help bring clarity to multi-dimensional data through real-world evidence and insights. - Cerner Enviza℠ aims to accelerate the discovery, development and delivery of extraordinary insights and therapies to improve everyday health for all people globally. By combining decades of healthcare innovation, life sciences knowledge and collaborative research, Cerner
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 61
  • Go to page 62
  • Go to page 63
  • Go to page 64
  • Go to page 65
  • Interim pages omitted …
  • Go to page 85
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |